WTA
KURA icon

Washington Trust Advisors’s Kura Oncology KURA Stock Holding History

Washington Trust Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-115
Closed -$1K – 651
2024
Q4 		$1K Hold
115
– – ﹤0.01% 638
2024
Q3 		$2.25K Hold
115
– – ﹤0.01% 631
2024
Q2 		$2.37K Hold
115
– – ﹤0.01% 622
2024
Q1 		$2.45K Hold
115
– – ﹤0.01% 632
2023
Q4 		$1.65K Hold
115
– – ﹤0.01% 649
2023
Q3 		$1.05K Hold
115
– – ﹤0.01% 662
2023
Q2 		$1.22K Hold
115
– – ﹤0.01% 643
2023
Q1 		$1.41K Hold
115
– – ﹤0.01% 750
2022
Q4 		$1.43K Hold
115
– – ﹤0.01% 750
2022
Q3 		$2K Hold
115
– – ﹤0.01% 856
2022
Q2 		$2K Hold
115
– – ﹤0.01% 881
2022
Q1 		$2K Hold
115
– – ﹤0.01% 951
2021
Q4 		$2K Buy
+115
New +$1.86K ﹤0.01% 960

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Washington Trust Advisors's KURA Position: Q1 2025 in Review

Washington Trust Advisors sold out of Kura Oncology (KURA) in Q1 2025, closing a stake of 115 shares — an estimated $1K sold.

Washington Trust Advisors first reported a position in KURA in Q4 2021 and held it in 13 quarters. The position peaked at $2.45K in Q1 2024. 183 funds tracked by Wall St. Rank hold KURA as of Q1 2025.

  • Washington Trust Advisors reported no remaining Kura Oncology position as of Q1 2025 after selling out during the quarter.
  • Washington Trust Advisors sold 115 Kura Oncology shares in Q1 2025, an estimated $1K.
  • Washington Trust Advisors first reported a position in Kura Oncology in Q4 2021 and held it in 13 quarters.
  • Washington Trust Advisors's Kura Oncology position peaked at $2.45K in Q1 2024.
  • 183 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2025.

Based on Washington Trust Advisors's 13F filing for Q1 2025, filed 25 Apr 2025.